MayAir Technology China Co Ltd
SSE:688376
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
MayAir Technology China Co Ltd
SSE:688376
|
CN |
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
IL |
Balance Sheet
Balance Sheet Decomposition
MayAir Technology China Co Ltd
MayAir Technology China Co Ltd
Balance Sheet
MayAir Technology China Co Ltd
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
56
|
77
|
117
|
1 022
|
838
|
1 013
|
|
| Cash |
56
|
77
|
117
|
1 022
|
838
|
1 013
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
51
|
0
|
|
| Total Receivables |
346
|
482
|
513
|
739
|
895
|
1 207
|
|
| Accounts Receivables |
287
|
382
|
399
|
616
|
755
|
1 011
|
|
| Other Receivables |
59
|
100
|
114
|
122
|
141
|
196
|
|
| Inventory |
328
|
371
|
341
|
431
|
500
|
592
|
|
| Other Current Assets |
41
|
38
|
68
|
49
|
50
|
69
|
|
| Total Current Assets |
770
|
968
|
1 040
|
2 240
|
2 334
|
2 845
|
|
| PP&E Net |
106
|
115
|
152
|
201
|
331
|
529
|
|
| PP&E Gross |
106
|
115
|
152
|
201
|
331
|
529
|
|
| Accumulated Depreciation |
41
|
50
|
64
|
88
|
117
|
157
|
|
| Intangible Assets |
31
|
31
|
30
|
47
|
250
|
249
|
|
| Goodwill |
0
|
0
|
0
|
2
|
2
|
2
|
|
| Note Receivable |
0
|
0
|
0
|
18
|
16
|
12
|
|
| Long-Term Investments |
1
|
3
|
3
|
2
|
2
|
2
|
|
| Other Long-Term Assets |
59
|
44
|
39
|
39
|
56
|
60
|
|
| Other Assets |
0
|
0
|
0
|
2
|
2
|
2
|
|
| Total Assets |
967
N/A
|
1 160
+20%
|
1 263
+9%
|
2 532
+100%
|
2 990
+18%
|
3 699
+24%
|
|
| Liabilities | |||||||
| Accounts Payable |
163
|
277
|
258
|
359
|
506
|
584
|
|
| Accrued Liabilities |
21
|
32
|
30
|
27
|
41
|
46
|
|
| Short-Term Debt |
242
|
274
|
299
|
395
|
351
|
353
|
|
| Current Portion of Long-Term Debt |
9
|
18
|
10
|
27
|
57
|
212
|
|
| Other Current Liabilities |
227
|
187
|
156
|
180
|
255
|
241
|
|
| Total Current Liabilities |
662
|
789
|
754
|
989
|
1 210
|
1 436
|
|
| Long-Term Debt |
29
|
10
|
37
|
48
|
121
|
440
|
|
| Deferred Income Tax |
0
|
0
|
0
|
7
|
6
|
7
|
|
| Minority Interest |
0
|
2
|
3
|
5
|
7
|
12
|
|
| Other Liabilities |
5
|
6
|
8
|
9
|
13
|
12
|
|
| Total Liabilities |
696
N/A
|
807
+16%
|
802
-1%
|
1 057
+32%
|
1 357
+28%
|
1 906
+40%
|
|
| Equity | |||||||
| Common Stock |
100
|
101
|
101
|
134
|
134
|
134
|
|
| Retained Earnings |
171
|
75
|
184
|
307
|
467
|
618
|
|
| Additional Paid In Capital |
0
|
178
|
178
|
1 036
|
1 036
|
1 042
|
|
| Unrealized Security Profit/Loss |
1
|
0
|
1
|
0
|
0
|
0
|
|
| Other Equity |
1
|
1
|
2
|
2
|
4
|
2
|
|
| Total Equity |
271
N/A
|
353
+30%
|
462
+31%
|
1 475
+219%
|
1 634
+11%
|
1 792
+10%
|
|
| Total Liabilities & Equity |
967
N/A
|
1 160
+20%
|
1 263
+9%
|
2 532
+100%
|
2 990
+18%
|
3 699
+24%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
134
|
134
|
134
|
134
|
134
|
134
|
|